|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Paller, Amy S.; Wollenberg, Andreas; Siegfried, Elaine; Thaci, Diamant; Cork, Michael J.; Arkwright, Peter D.; Gooderham, Melinda; Sun, Xian; O'Malley, John T.; Khokhar, Faisal A.; Vakil, Jignesh; Bansal, Ashish; Rosner, Karli; Shumel, Brad und Levit, Noah A.
(2021):
Laboratory Safety of Dupilumab in Patients Aged 6-11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial.
In: Pediatric Drugs, Bd. 23, Nr. 5: S. 515-527
Silverberg, Jonathan I.; Guttman-Yassky, Emma; Gooderham, Melinda; Worm, Margitta; Rippon, Stephanie; O'Quinn, Sean; Merwe, Rene van der; Kragh, Nana; Kurbasic, Azra und Wollenberg, Andreas
(2021):
Health-related quality of life with tralokinumab in moderate-to-severe atopic dermatitis A phase 2b randomized study.
In: Annals of Allergy Asthma & Immunology, Bd. 126, Nr. 5: S. 576-583
Paller, Amy S.; Siegfried, Elaine C.; Thaci, Diamant; Wollenberg, Andreas; Cork, Michael J.; Arkwright, Peter D.; Gooderham, Melinda; Beck, Lisa A.; Boguniewicz, Mark; Sher, Lawrence; Weisman, Jamie; O'Malley, John T.; Patel, Naimish; Hardin, Megan; Graham, Neil M. H.; Ruddy, Marcella; Sun, Xian; Davis, John D.; Kamal, Mohamed A.; Khokhar, Faisal A.; Weinreich, David M.; Yancopoulos, George D.; Beazley, Bethany; Bansal, Ashish und Shumel, Brad
(2020):
Efficacy and safety of dupilumab with concomitant topical corticosteroids in children 6 to 11 years old with severe atopic dermatitis: A randomized, double-blinded, placebo-controlled phase 3 trial.
In: Journal of the American Academy of Dermatology, Bd. 83, Nr. 5: S. 1282-1293